Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jun 2020 | $103 M | No. 3 | $50 to $250 million | equity | SEC | |
| Dec 2015 | $15 M | No. 2 | $10 to $50 million | debt, options | SEC | |
| Aug 2014 | $8 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Cue Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2020).
SEC Form D · Jun 2020
The industry group it chose in its notices: Other Health Care.
SEC Form D · Jun 2020
That is all the official record says: Cue Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
11 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Christopher K. Achar | Person | not stated | not stated | Held Series B preferred stock, director (Form 3, 2021) | SEC Form 3 |
| Cove Investors II, LLC | Fund or asset manager | not stated | not stated | Held Series A, B and C-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Cove Investors I, LLC | Fund or asset manager | not stated | not stated | Held Series A, B and C-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Decheng Capital China Life Sciences USD Fund III, L.P. | Fund or asset manager | not stated | not stated | Held Series C-1 preferred stock, 10% owner, director (Form 3, 2021) | SEC Form 3 |
| Decheng Capital Management III (Cayman), LLC | Fund or asset manager | not stated | not stated | Held Series C-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Section 32 Fund 2, LP | Fund or asset manager | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Section 32 GP 2, LLC | Other | not stated | not stated | Held Series B preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Sherpa Ventures Fund GP, LLC | Venture capital | not stated | not stated | Held Series A, B and C-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SherpaVentures Fund II GP, LLC | Venture capital | not stated | not stated | Held Series A, B and C-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| SherpaVentures Fund II, LP | Venture capital | not stated | not stated | Held Series A, B and C-1 preferred stock, 10% owner (Form 3, 2021) | SEC Form 3 |
| Sherpa Ventures Fund, LP | Venture capital | not stated | not stated | Held Series A, B and C-1 preferred stock, 10% owner, director (Form 3, 2021) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 22 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Ayub Khattak | Executive officer | Jun 2020 |
| Clint Sever | Executive officer | Jun 2020 |
| Ayub Khattak | Director | Jun 2020 |
| Chris Achar | Director | Jun 2020 |
| Min Cui | Director | Jun 2020 |
| Robin Farias Eisner | Director | Jun 2020 |
| Rohan Oza | Director | Jun 2020 |
| Scott Stanford | Director | Jun 2020 |
| Shervin Pishevar | Director | May 2017 |
| Ayub Khattak | Promoter | Dec 2014 |